Skip to Content

293 Results Found

  • Review
  • Open Access
48 Citations
7,967 Views
27 Pages

Immune Checkpoint Inhibitors in pMMR Metastatic Colorectal Cancer: A Tough Challenge

  • Federica Marmorino,
  • Alessandra Boccaccino,
  • Marco Maria Germani,
  • Alfredo Falcone and
  • Chiara Cremolini

17 August 2020

The introduction of checkpoint inhibitors provided remarkable achievements in several solid tumors but only 5% of metastatic colorectal cancer (mCRC) patients, i.e., those with bearing microsatellite instable (MSI-high)/deficient DNA mismatch repair...

(This article belongs to the Special Issue Metastatic Colorectal Cancer)
  • Article
  • Open Access
2 Citations
969 Views
14 Pages

17 December 2025

Background: The benefit of adjuvant chemotherapy for low-risk, mismatch repair proficient (pMMR) stage IIA colon cancer is uncertain. Surveillance is standard, but some patients relapse. Tegafur-uracil (UFT) is a low-toxicity oral option that may off...

(This article belongs to the Special Issue Contemporary Therapeutic Strategies for Solid Tumors)
  • Review
  • Open Access
23 Citations
7,289 Views
35 Pages

Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma

  • María San-Román-Gil,
  • Javier Torres-Jiménez,
  • Javier Pozas,
  • Jorge Esteban-Villarrubia and ,
  • Víctor Albarrán-Fernández,
  • Pablo Álvarez-Ballesteros,
  • Jesús Chamorro-Pérez,
  • Diana Rosero-Rodríguez,
  • Inmaculada Orejana-Martín and
  • Reyes Ferreiro-Monteagudo
  • + 8 authors+ 3 authors

30 January 2023

Colorectal cancer (CRC) is the third most frequent cancer and the second most common cause of cancer-related death in Europe. High microsatellite instability (MSI-H) due to a deficient DNA mismatch repair (dMMR) system can be found in 5% of metastati...

(This article belongs to the Topic Metastatic Colorectal Cancer: From Laboratory to Clinical Studies)
  • Review
  • Open Access
5 Citations
5,493 Views
20 Pages

The Efficacy of Pembrolizumab Immunotherapy in the Treatment of Endometrial Cancer: A Systematic Review

  • Natalia Picheta,
  • Julia Piekarz,
  • Krzysztof Kułak and
  • Rafał Tarkowski

9 September 2025

Endometrial cancer represents one of the most common gynecological cancers in women. In recent years, there has been increasing interest in immunotherapy, including the use of pembrolizumab, particularly for the treatment of cancers with deficient mi...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
5 Citations
3,896 Views
12 Pages

Evaluation of Microsatellite Instability Molecular Analysis versus Immuno-Histochemical Interpretation in Malignant Neoplasms with Different Localizations

  • Maria Sfakianaki,
  • Maria Tzardi,
  • Konstantina Tsantaki,
  • Chara Koutoulaki and ,
  • Ippokratis Messaritakis,
  • Galateia Datseri,
  • Eleni Moustou,
  • Dimitrios Mavroudis and
  • John Souglakos
  • + 4 authors+ 0 author

5 January 2023

MMR gene germline mutations are considered a major genetic disorder in patients with hereditary nonpolyposis colon cancer (HNPCC) or Lynch syndrome; A total of 15% of sporadic colon carcinomas are MSI-High. MSI has also been observed in other cancers...

(This article belongs to the Collection Targeting Solid Tumors)
  • Article
  • Open Access
12 Citations
3,849 Views
14 Pages

The Impact of Tumor Cell-Intrinsic Expression of Cyclic GMP-AMP Synthase (cGAS)-Stimulator of Interferon Genes (STING) on the Infiltration of CD8+ T Cells and Clinical Outcomes in Mismatch Repair Proficient/Microsatellite Stable Colorectal Cancer

  • Shotaro Nakajima,
  • Akinao Kaneta,
  • Hirokazu Okayama,
  • Katsuharu Saito and ,
  • Tomohiro Kikuchi,
  • Eisei Endo,
  • Takuro Matsumoto,
  • Satoshi Fukai,
  • Mei Sakuma and
  • Koji Kono
  • + 12 authors+ 7 authors

18 May 2023

The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway plays a crucial role in activating immune cells in the tumor microenvironment, thereby contributing to a more favorable response to immune checkpoint inhibitors (ICI) i...

(This article belongs to the Special Issue Immunity and Gastrointestinal Cancer)
  • Article
  • Open Access
775 Views
11 Pages

Immunohistochemical Changes in MMR Status, ER/PR, and p53 Expression in Recurrent Endometrial Carcinomas

  • Zeliha Guzeloz,
  • Ozce Kutlu,
  • Ozgur Erdogan,
  • Gonul Demir and ,
  • Bugra Taygun Gulle,
  • Muzaffer Sancı,
  • Mihriban Erdogan and
  • Canan Kelten Talu
  • + 3 authors+ 0 author

27 April 2026

Background and Objectives: The aim of this study is to assess the mismatch repair (MMR) status and immunohistochemical changes in cases of recurrent endometrial cancer following primary surgery and to evaluate the impact of these changes on prognosis...

(This article belongs to the Special Issue Endometrial Cancer: Biomarkers and Management (2nd Edition))
  • Article
  • Open Access
1 Citations
6,519 Views
16 Pages

DNA Mismatch Repair Proteins and BRAF V600E Detection by Immunohistochemistry in Colorectal Cancer Demonstrates Concordance with Next Generation Sequencing

  • Joel Yambert,
  • Leigh A. Henricksen,
  • June Clements,
  • Andrew Hannon and ,
  • Alyssa Jordan,
  • Shalini Singh,
  • Katerina Dvorak,
  • Colin C. Pritchard and
  • Eric Q. Konnick
  • + 4 authors+ 0 author

2 December 2022

Background and Aims: Multiple laboratory methods are used to screen patients with colorectal cancer (CRC) for mismatch repair (MMR) protein deficiency to identify possible Lynch syndrome patients. The goal of this study was to compare the agreement b...

(This article belongs to the Topic Diagnostic Imaging and Pathology in Cancer Research)
  • Article
  • Open Access
384 Views
13 Pages

Molecular Profile of Advanced Endometrial Cancer (FIGO III–IV) in a Polish Multicentre Cohort: Clinicopathological Characterisation and Treatment Implications

  • Wiktor Szatkowski,
  • Aleksandra Dudek,
  • Katarzyna Franczyk,
  • Małgorzata Nowak-Jastrząb and ,
  • Tomasz Kluz,
  • Małgorzata Cieślak-Steć,
  • Magdalena Śliwińska and
  • Paweł Blecharz
  • + 3 authors+ 0 author

11 September 2026

Background/Objectives: Advanced endometrial cancer (FIGO III–IV) is characterised by poor prognosis and a heterogeneous biological profile, and molecular classification enables treatment personalisation by identifying subtypes with distinct the...

(This article belongs to the Special Issue Current and Emerging Management Strategies in Gynecologic Oncology)
  • Article
  • Open Access
6 Citations
7,109 Views
12 Pages

TP53 Abnormalities and MMR Preservation in 5 Cases of Proliferating Trichilemmal Tumours

  • Raquel Martín-Sanz,
  • José María Sayagués,
  • Pilar García-Cano,
  • Mikel Azcue-Mayorga and ,
  • María del Carmen Parra-Pérez,
  • María Ángeles Pacios-Pacios,
  • Enric Piqué-Durán and
  • Jorge Feito
  • + 3 authors+ 0 author

Proliferating trichilemmal tumours (PTT) are defined by a benign squamous cell proliferation inside a trichilemmal cystic (TC) cavity. A possible explanation of this proliferative phenomenon within the cyst may be molecular alterations in genes assoc...

(This article belongs to the Section Molecular Dermatopathology)
  • Review
  • Open Access
7 Citations
9,084 Views
19 Pages

Autopsy by Imaging: The Last 10 Years

  • Ellie Mercala and
  • Emyr Wyn Benbow

27 October 2022

Virtual autopsies (VAs) are non-invasive, bypassing many of the challenges posed by traditional autopsies (TAs). This is a literature review about the sensitivity of the main VA techniques: post mortem (PM) computed tomography (PMCT) and PM magnetic...

(This article belongs to the Special Issue Feature Papers in Forensic Sciences in 2022)
  • Article
  • Open Access
1,230 Views
14 Pages

Prognostic Impact of Blood Tumor Mutational Burden in pMMR/MSS Metastatic Colorectal Cancer Assessed by FoundationOne® Liquid CDx

  • Benoist Chibaudel,
  • Elisabeth Carola,
  • Hamid Mekranter,
  • Perrine Goyer and ,
  • Arnaud Saget,
  • Olivier Oberlin,
  • Hélène Marijon,
  • Hubert Richa,
  • Ida Iurisci and
  • Aimery de Gramont
  • + 13 authors+ 8 authors

4 February 2026

Background/Objectives: The prognostic significance of blood tumor mutational burden (bTMB) in metastatic colorectal cancer (mCRC) remains poorly defined. While tissue-based TMB has been associated with favorable outcomes in selected colorectal cancer...

(This article belongs to the Section Cancer Pathophysiology)
  • Article
  • Open Access
1 Citations
919 Views
12 Pages

Association of Molecular Classification with FIGO Stage and Survival Outcomes in Endometrial Cancer

  • Merve Keskinkılıç,
  • Gül Polat,
  • Zeynep Bayramoğlu,
  • Anıl Aysal Ağalar and ,
  • Göksenil Bülbül Öztürk,
  • Emine Çağnur Ulukuş,
  • Tuğba Yavuzşen and
  • İlhan Öztop
  • + 3 authors+ 0 author

29 April 2026

Background and Objectives: Molecular classification has emerged as a key determinant of prognosis in endometrial cancer and has recently been incorporated into the 2023 FIGO staging system. Tumors are categorized into four molecular subgroups—P...

(This article belongs to the Section Oncology)
  • Review
  • Open Access
22 Citations
5,937 Views
15 Pages

The Gut Microbiome, Microsatellite Status and the Response to Immunotherapy in Colorectal Cancer

  • Toritseju O. Sillo,
  • Andrew D. Beggs,
  • Gary Middleton and
  • Akinfemi Akingboye

There is increasing evidence in a range of cancer types that the microbiome plays a direct role in modulating the anti-cancer immune response both at the gut level and systemically. Differences in the gut microbiota have been shown to correlate with...

(This article belongs to the Special Issue Latest Review Papers in Molecular Oncology 2023)
  • Brief Report
  • Open Access
841 Views
9 Pages

Impact of the COVID-19 Pandemic on Routine Childhood Vaccination in Oklahoma

  • Jessica Beetch,
  • Laura A. Beebe,
  • Amanda Janitz,
  • Chao Xu and ,
  • Mary Gowin and
  • Katrin Gaardbo Kuhn
  • + 1 author+ 0 author

19 March 2026

Background/Objectives: The COVID-19 pandemic substantially disrupted routine childhood vaccination practices across the United States. Oklahoma, a state characterized by lower socioeconomic indicators and higher levels of vaccine hesitancy, may have...

(This article belongs to the Section Epidemiology and Vaccination)
  • Article
  • Open Access
4 Citations
3,035 Views
16 Pages

Implementing an On-Slide Molecular Classification of Gastric Cancer: A Tissue Microarray Study

  • Simona Costache,
  • Rebecca de Havilland,
  • Sofia Diaz McLynn,
  • Maria Sajin and ,
  • Adelina Baltan,
  • Sarah Wedden and
  • Corrado D’Arrigo
  • + 2 authors+ 0 author

21 December 2023

Background and Objectives: Gastric cancer (GC) is one of the most commonly diagnosed cancers and the fourth cause of cancer death worldwide. Personalised treatment improves GC outcomes. A molecular classification is needed to choose the appropriate t...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Article
  • Open Access
35 Citations
6,053 Views
17 Pages

PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer

  • Gianluca Lopez,
  • Marianna Noale,
  • Chiara Corti,
  • Gabriella Gaudioso and ,
  • Elham Sajjadi,
  • Konstantinos Venetis,
  • Donatella Gambini,
  • Letterio Runza,
  • Jole Costanza and
  • Nicola Fusco
  • + 10 authors+ 5 authors

21 February 2020

Mismatch repair (MMR) analysis in breast cancer may help to inform immunotherapy decisions but it lacks breast-specific guidelines. Unlike in other neoplasms, MMR protein loss shows intra-tumor heterogeneity and it is not mirrored by microsatellite i...

(This article belongs to the Special Issue Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches)
  • Review
  • Open Access
982 Views
18 Pages

Immunotherapy in Endometrial Cancer: Molecular Classification, Clinical Evidence, and Therapeutic Implications: A Narrative Review

  • Pablo Padilla-Iserte,
  • Silvia Cabrera,
  • Sonia Gatius Calderó,
  • Ana de Juan Ferré and ,
  • Katarina Majercakova,
  • María Jesús Rubio-Pérez,
  • Ignacio Romero,
  • Maria Pilar Barretina-Ginesta and
  • Manel Barahona Orpinell
  • + 4 authors+ 0 author

24 May 2026

Background/Objectives: Endometrial cancer (EC) is the most common gynecologic malignancy in developed countries, with increasing incidence and limited options in advanced disease. Molecular classification has redefined risk stratification and therape...

(This article belongs to the Special Issue Endometrial Cancer Therapy: Foundations and Future Directions)
  • Article
  • Open Access
7 Citations
3,674 Views
13 Pages

Detecting Microsatellite Instability in Endometrial, Colon, and Stomach Cancers Using Targeted NGS

  • Ulyana Boyarskikh,
  • Andrey Kechin,
  • Evgeniy Khrapov,
  • Mikhail Fedyanin and ,
  • Grigory Raskin,
  • Marina Mukhina,
  • Elena Kravtsova,
  • Aleksey Tsukanov,
  • Sergey Achkasov and
  • Maksim Filipenko
  • + 5 authors+ 0 author

20 October 2023

Purpose: To develop a method for testing the MSI based on targeted NGS. Methods: Based on the results of previous studies, 81 microsatellite loci with high variability in MSI-H tumors were selected, and a method for calculating the MSI score was deve...

(This article belongs to the Collection Targeting Solid Tumors)
  • Article
  • Open Access
730 Views
26 Pages

Background/Objectives: Temporal predictability may sharpen our ability to distinguish similar sounds, but whether this relies on attention is unclear. This study examined how temporal structure influences frequency discrimination. Methods: Thirty-six...

(This article belongs to the Special Issue Predictive Processing in Brain and Behavior)
  • Article
  • Open Access
6 Citations
4,058 Views
15 Pages

Infiltration of Apoptotic M2 Macrophage Subpopulation Is Negatively Correlated with the Immunotherapy Response in Colorectal Cancer

  • Rui Liu,
  • Chongyin Han,
  • Jiaqi Hu,
  • Baowen Zhang and ,
  • Wei Luo and
  • Fei Ling
  • + 1 author+ 0 author

20 September 2022

The polarization of tumor-associated macrophages (TAMs) plays a key role in tumor development and immunotherapy in colorectal cancer (CRC) patients. However, the impact of apoptosis on TAM polarization and immunotherapy efficacy in patients with diff...

(This article belongs to the Special Issue Molecular Regulation of Cancer Cell Migration, Invasion, and Metastasis)
  • Article
  • Open Access
14 Citations
4,446 Views
15 Pages

A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma

  • Alexandre Harari,
  • Apostolos Sarivalasis,
  • Kaat de Jonge,
  • Anne-Christine Thierry and ,
  • Florian Huber,
  • Caroline Boudousquie,
  • Laetitia Rossier,
  • Angela Orcurto,
  • Martina Imbimbo and
  • Lana E. Kandalaft
  • + 7 authors+ 2 authors

18 November 2021

Endometrial cancer (EC) is a common gynecological malignancy and the fourth most common malignancy in European and North American women. Amongst EC, the advanced serous, p53-mutated, and pMMR subtypes have the highest risk of relapse despite optimal...

(This article belongs to the Special Issue Endometrial Cancer: Old Questions and New Perspectives)
  • Article
  • Open Access
1 Citations
2,010 Views
12 Pages

Association Between MMR Status and Prognostic Pathological Factors in Endometrioid Endometrial Cancer—A Single-Center Retrospective Study

  • Cezary Miedziarek,
  • Hubert Bochyński,
  • Katarzyna Bociańska,
  • Michał Potograbski and ,
  • Piotr Tyburski,
  • Mikołaj Piotr Zaborowski and
  • Ewa Nowak-Markwitz
  • + 2 authors+ 0 author

8 November 2025

Background/Objectives: Prognostic assessment in endometrial cancer (EC) is based on clinical and pathological features such as histological type, FIGO stage, tumor grade, LVSI, P53 status, and hormone receptor expression. Recent molecular research ha...

(This article belongs to the Section Cancer Pathophysiology)
  • Article
  • Open Access
2 Citations
2,991 Views
12 Pages

Heparanase (HPSE) Associates with the Tumor Immune Microenvironment in Colorectal Cancer

  • Mengling Liu,
  • Qing Liu,
  • Yitao Yuan,
  • Suyao Li and ,
  • Yu Dong,
  • Li Liang,
  • Zhiguo Zou and
  • Tianshu Liu
  • + 3 authors+ 0 author

7 September 2021

There is an unmet clinical need to identify potential predictive biomarkers for immunotherapy efficacy in mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC). Heparanase (HPSE) is a multifunctional molecule mediating tumor–host cros...

(This article belongs to the Section Biological Processes and Systems)
  • Article
  • Open Access
2 Citations
4,101 Views
18 Pages

Although allophonic speech processing has been hypothesized to be a contributing factor in developmental dyslexia, experimental evidence is limited and inconsistent. The current study compared the categorization of native similar sounding vowels of t...

(This article belongs to the Special Issue Neurobiological Basis of Developmental Dyslexia)
  • Systematic Review
  • Open Access
27 Citations
5,553 Views
18 Pages

Efficacy and Safety of PD-1/PD-L1 Inhibitor as Single-Agent Immunotherapy in Endometrial Cancer: A Systematic Review and Meta-Analysis

  • Mohd Nazzary Mamat @ Yusof,
  • Kah Teik Chew,
  • Abdul Muzhill Hannaan Abdul Hafizz,
  • Siti Hajar Abd Azman and ,
  • Wira Sofran Ab Razak,
  • Muhammad Rafi’uddin Hamizan,
  • Nirmala Chandralega Kampan and
  • Mohamad Nasir Shafiee
  • + 3 authors+ 0 author

9 August 2023

The programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) pathway plays a crucial role in the immune escape mechanism and growth of cancer cells in endometrial cancer (EC). Clinical trials investigating PD-1/PD-L1 inhibitor ha...

(This article belongs to the Special Issue Endometrial Cancer: Old Questions and New Perspectives (Volume II))
  • Article
  • Open Access
2 Citations
2,555 Views
12 Pages

Prevalence of Mismatch Repair Deficiency in Advanced Solid Tumors (Colorectal Cancer and Non-Colorectal Cancer) in One Mexican Institution

  • Rita Dorantes-Heredia,
  • Daniel Motola-Kuba,
  • Ixel Escamilla-López,
  • Eduardo Téllez-Bernal and ,
  • Emilio Conde-Flores,
  • Daniel Escalera-Santamaría,
  • Emilio Medina-Ceballos,
  • José Ruiz-Morales,
  • Elena Dorokhova and
  • Georgina del C. Filio-Rodríguez
  • + 7 authors+ 2 authors

13 December 2024

Background/Objectives: Mismatch repair (MMR) status is an important prognostic and predictive indicator in cancer, distinguishing proficient (pMMR) tumors from deficient (dMMR) ones. This study aimed to determine the prevalence of dMMR in colorectal...

(This article belongs to the Section Disease Biomarkers)
  • Article
  • Open Access
1 Citations
2,063 Views
11 Pages

Effects of Microsatellite Instability on the Clinical and Pathological Characteristics of Colon Cancer and the Diagnostic Accuracy of Preoperative Abdominal CT Scans

  • Rıdvan Yavuz,
  • Orhan Aras,
  • Hüseyin Çiyiltepe,
  • Onur İlkay Dinçer and ,
  • Ahmet Şükrü Alparslan and
  • Tebessüm Çakır
  • + 1 author+ 0 author

Background: Microsatellite-stable (MSS) and microsatellite-instable (MSI) colon cancer (CC) cases have different characteristics. These characteristics may impact the accuracy of abdominal computed tomography (CT) scan examinations in MSI CC. Methods...

(This article belongs to the Section Clinical Diagnosis and Prognosis)
  • Systematic Review
  • Open Access
2,107 Views
18 Pages

Increasing the Response of Mismatch Repair Proficient Rectal Cancer to Immunotherapy with Particle Radiation and DNA Damage Response Inhibitors—Preclinical Evidence

  • Cristian J. Salazar-Vilches,
  • Daniel K. Ebner,
  • Jake A. Kloeber,
  • Sonja Dragojevic and ,
  • Jasvinder Singh,
  • Michael Haddock,
  • Yasamin Sharifzadeh,
  • Alexander D. Sherry,
  • Krishan R. Jethwa and
  • Cameron M. Callaghan
  • + 9 authors+ 4 authors

19 February 2026

Background/Objectives: We performed a systematic review of preclinical literature on the use of high-LET particle therapy, DDRi, and/or immunotherapy specifically in pMMR colorectal cancer. Methods: A systematic review of the literature published bet...

(This article belongs to the Special Issue Advances in Radiotherapy of Gastrointestinal Cancers)
  • Article
  • Open Access
3 Citations
1,863 Views
15 Pages

Analysis of Consensus Molecular Subtypes of Colorectal Cancer in Oman with Clinicopathologic Correlation

  • Shaista Rehman,
  • Asem Shalaby,
  • Said A. Al-Busafi,
  • Moon Fai Chan and ,
  • Shaima Al Khabouri,
  • Mustafa Al Hinai,
  • Adhari Al Zaabi,
  • Mohammad Al Masqari,
  • Asim Qureshi and
  • Mohammed Al-Azri
  • + 5 authors+ 0 author

21 February 2026

Colorectal cancer (CRC) is a major public health challenge in Oman and a leading cause of cancer-related mortality. The rising incidence has been associated with lifestyle changes, urbanization, and genetic factors. The CRC Subtyping Consortium has d...

(This article belongs to the Special Issue Novel Therapeutic Targets in Cancers: 4th Edition)
  • Review
  • Open Access
1,883 Views
39 Pages

Redefining the Treatment Landscape of Advanced Endometrial Cancer in the Era of Immunotherapy and Precision Oncology

  • Martina Cassaniti,
  • Ilaria Morelli,
  • Anna Chiara Boschi,
  • Simona Scodes and ,
  • Giuseppe Comerci,
  • Claudia Casanova and
  • Stefano Tamberi
  • + 2 authors+ 0 author

4 June 2026

The therapeutic landscape of advanced and recurrent endometrial cancer (EC) has evolved substantially in recent years due to the integration of molecular classification and novel systemic therapies. This review summarizes current treatment strategies...

(This article belongs to the Special Issue Feature Review for Cancer Therapy: 2nd Edition)
  • Review
  • Open Access
58 Citations
10,319 Views
17 Pages

Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer

  • Iosune Baraibar,
  • Oriol Mirallas,
  • Nadia Saoudi,
  • Javier Ros and ,
  • Francesc Salvà,
  • Josep Tabernero and
  • Elena Élez
  • + 2 authors+ 0 author

16 December 2021

In recent years, deepening knowledge of the complex interactions between the immune system and cancer cells has led to the advent of effective immunotherapies that have revolutionized the therapeutic paradigm of several cancer types. However, colorec...

(This article belongs to the Special Issue Combination Therapy Strategies for Cancer PD-1/PD-L1 Pathway Blockade Awareness)
  • Review
  • Open Access
26 Citations
7,202 Views
19 Pages

6 April 2020

Immunotherapy has considerably increased the number of anticancer agents in many tumor types including metastatic colorectal cancer (mCRC). Anti-PD-1 (programmed death 1) and cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) immune checkpoin...

  • Article
  • Open Access
6 Citations
2,717 Views
13 Pages

Background: Inspired by the molecular classification of endometrial carcinoma (EC) proposed by The Cancer Genome Atlas Research Network (TCGA), we investigated tumor-infiltrating CD8-positive T-cell as well as DNA mismatch repair (MMR) protein and p5...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
2,062 Views
11 Pages

Risk for Hereditary Neoplastic Syndromes in Women with Mismatch Repair-Proficient Endometrial Cancer

  • Jennifer Thalita Targino dos Santos,
  • Reginaldo Cruz Alves Rosa,
  • Alison Luis Eburneo Pereira,
  • Alan Vinicius Assunção-Luiz and ,
  • Bruna Tavares Bacalá,
  • Victor Evangelista de Faria Ferraz and
  • Milena Flória
  • + 2 authors+ 0 author

26 October 2023

Endometrial cancer (EC) is a prevalent malignancy in women, and those who are proficient in the DNA mismatch repair (pMMR) pathway may have a family history (FH) that meets the criteria for a hereditary neoplastic condition (HNS). This study aimed to...

(This article belongs to the Section Technologies and Resources for Genetics)
  • Article
  • Open Access
7 Citations
2,820 Views
16 Pages

Mismatch Repair Deficiency Is a Prognostic Factor Predicting Good Survival of Opisthorchis viverrini-Associated Cholangiocarcinoma at Early Cancer Stage

  • Natcha Khuntikeo,
  • Sureerat Padthaisong,
  • Watcharin Loilome,
  • Poramate Klanrit and ,
  • Soontaree Ratchatapusit,
  • Anchalee Techasen,
  • Apiwat Jareanrat,
  • Vasin Thanasukarn,
  • Tharatip Srisuk and
  • Attapol Titapun
  • + 12 authors+ 7 authors

2 October 2023

Background: The mismatch repair (MMR) system prevents DNA mutation; therefore, deficient MMR protein (dMMR) expression causes genetic alterations and microsatellite instability (MSI). dMMR is correlated with a good outcome and treatment response in v...

(This article belongs to the Section Cancer Pathophysiology)
  • Review
  • Open Access
12 Citations
6,047 Views
30 Pages

28 October 2023

Colorectal cancer (CRC) is the third most frequent cancer and the second leading cause of cancer-related deaths in Europe. About 5% of metastatic CRC (mCRC) are characterized by high microsatellite instability (MSI) due to a deficient DNA mismatch re...

(This article belongs to the Special Issue Metastatic Colorectal Cancer 2.0)
  • Article
  • Open Access
3 Citations
3,856 Views
12 Pages

Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer

  • Dae Won Kim,
  • Young-Chul Kim,
  • Bence P. Kovari,
  • Maria Martinez and ,
  • Ruoyu Miao,
  • James Yu,
  • Rutika Mehta,
  • Jonathan Strosberg,
  • Iman Imanirad and
  • Richard D. Kim
  • + 5 authors+ 0 author

28 January 2024

Previously, we reported the modest but durable anticancer activity of regorafenib/nivolumab in mismatch repair-proficient (pMMR) refractory colorectal cancer in our I/Ib study. Our finding suggests the necessity of biomarkers for better selection of...

(This article belongs to the Special Issue New Biomarkers in Cancers 2nd Edition)
  • Review
  • Open Access
14 Citations
6,382 Views
21 Pages

Immunotherapy in GI Cancers: Lessons from Key Trials and Future Clinical Applications

  • Supriya Peshin,
  • Faizan Bashir,
  • Naga Anvesh Kodali,
  • Adit Dharia and ,
  • Sajida Zaiter,
  • Sakshi Singal and
  • Nagaishwarya Moka
  • + 2 authors+ 0 author

Immunotherapy has emerged as a transformative approach in gastrointestinal (GI) cancers, addressing historically poor survival rates in advanced-stage disease. Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis demonstrate remarkable e...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
18 Citations
5,598 Views
13 Pages

Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer

  • Marta Mendiola,
  • Victoria Heredia-Soto,
  • Ignacio Ruz-Caracuel,
  • Amparo Baillo and ,
  • Jorge Luis Ramon-Patino,
  • Francisco Javier Escudero,
  • Maria Miguel,
  • Alberto Pelaez-Garcia,
  • Alicia Hernandez and
  • Andres Redondo
  • + 7 authors+ 2 authors

23 September 2023

Approximately 20–30% of endometrial carcinomas (EC) are characterized by mismatch repair (MMR) deficiency (dMMR) or microsatellite instability (MSI), and their testing has become part of the routine diagnosis. The aim of this study was to estab...

(This article belongs to the Section Molecular Oncology)
  • Review
  • Open Access
1 Citations
1,816 Views
59 Pages

Paradigm Shifts in Perioperative Management of Colorectal Cancer: Personalization Based on Tumor Biology, Primary Site, and Recurrence Risk, and the Evolving Role of Organ Preservation

  • Kaoru Yoshikawa,
  • Akira Ooki,
  • Eiji Shinozaki,
  • Eiichiro Toyokawa and ,
  • Keito Suzuki,
  • Manabu Shiozawa,
  • Shin Maeda,
  • Kensei Yamaguchi and
  • Hiroki Osumi
  • + 4 authors+ 0 author

14 August 2026

Perioperative treatment for colorectal cancer (CRC) is undergoing a paradigm shift from uniform cytotoxic regimens toward strategies guided by tumor location, microsatellite instability (MSI)/mismatch repair (MMR) status, and recurrence risk. Four cl...

(This article belongs to the Special Issue Colorectal Cancers: New Approach to Their Pathology, Diagnosis and Therapy)
  • Article
  • Open Access
29 Citations
4,937 Views
18 Pages

Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry

  • Federica Zito Marino,
  • Martina Amato,
  • Andrea Ronchi,
  • Iacopo Panarese and ,
  • Franca Ferraraccio,
  • Ferdinando De Vita,
  • Giuseppe Tirino,
  • Erika Martinelli,
  • Teresa Troiani and
  • Renato Franco
  • + 21 authors+ 16 authors

28 April 2022

Background: Microsatellite instability (MSI) is a predictive biomarker for immune checkpoint inhibitors. The main goal was to investigate the discordance between IHC and PCR/NGS for MSI testing in gastrointestinal cancers. Methods: Two series were an...

(This article belongs to the Special Issue Gastrointestinal Malignancies in the Era of Precision Oncology: From Bench to Bedside and Back Again)
  • Systematic Review
  • Open Access
1 Citations
1,434 Views
24 Pages

Clinical Evidence on Particle Radiation, DNA Damage Response Inhibitors, and Immunotherapy for Mismatch Repair-Proficient Rectal Cancer

  • Cristian J. Salazar-Vilches,
  • Daniel K. Ebner,
  • Jake A. Kloeber,
  • Sonja Dragojevic and ,
  • Jasvinder Singh,
  • Michael Haddock,
  • Yasamin Sharifzadeh,
  • Alexander D. Sherry,
  • Krishan R. Jethwa and
  • Cameron M. Callaghan
  • + 9 authors+ 4 authors

17 February 2026

Background/Objectives: We performed a systematic review of the current clinical and preclinical literature on the use of particle therapy, DDRi, and/or immunotherapy, specifically for pMMR colorectal cancer. Methods: A systematic review of the litera...

(This article belongs to the Special Issue Advances in Radiotherapy of Gastrointestinal Cancers)
  • Article
  • Open Access
18 Citations
5,010 Views
16 Pages

Immune Contexture of MMR-Proficient Primary Colorectal Cancer and Matched Liver and Lung Metastases

  • Maarit Ahtiainen,
  • Hanna Elomaa,
  • Juha P. Väyrynen,
  • Erkki-Ville Wirta and ,
  • Teijo Kuopio,
  • Olli Helminen,
  • Toni T. Seppälä,
  • Ilmo Kellokumpu and
  • Jukka-Pekka Mecklin
  • + 4 authors+ 0 author

26 March 2021

Purpose: To evaluate immune cell infiltration, the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) expression and their prognostic value in a series of mismatch proficient (pMMR) CRC with matched liver and lung metastases. Methods: Formalin...

(This article belongs to the Special Issue Colorectal Liver Metastasis)
  • Article
  • Open Access
12 Citations
5,641 Views
14 Pages

Ovarian Mesonephric-like Adenocarcinoma: Its Prevalence in a Japanese High-Volume Cancer Center and a Literature Review on Therapeutic Targets

  • Ayako Ogawa,
  • Hiroshi Yoshida,
  • Saria Kawano,
  • Nao Kikkawa and ,
  • Mayumi Kobayashi-Kato,
  • Yasuhito Tanase,
  • Masaya Uno and
  • Mitsuya Ishikawa
  • + 3 authors+ 0 author

30 August 2024

Background: Ovarian mesonephric-like adenocarcinoma (MLA) is a newly described histological type known for its aggressive behavior. This study aims to determine the frequency of ovarian MLA, review the existing literature, and elucidate its clinicopa...

(This article belongs to the Special Issue Ovarian Cancer in the Age of Precision Medicine)
  • Article
  • Open Access
44 Citations
6,363 Views
16 Pages

Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting

  • Umberto Malapelle,
  • Paola Parente,
  • Francesco Pepe,
  • Caterina De Luca and ,
  • Pasquale Pisapia,
  • Roberta Sgariglia,
  • Mariantonia Nacchio,
  • Gianluca Gragnano,
  • Gianluca Russo and
  • Paolo Graziano
  • + 17 authors+ 12 authors

24 July 2021

Immune-checkpoint inhibitors (ICIs) play a key role in the treatment of advanced stage colorectal cancer (CRC) patients featuring a deficient DNA mismatch repair (dMMR) system or a high microsatellite instability (MSI-H) profile. However, beyond the...

(This article belongs to the Collection Feature Papers in ‘Cellular Immunology’)
  • Review
  • Open Access
3 Citations
3,200 Views
13 Pages

Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway

  • Daniela Luvero,
  • Gianna Barbara Cundari,
  • Fernando Ficarola,
  • Francesco Plotti and ,
  • Corrado Terranova,
  • Roberto Montera,
  • Giorgio Bogani,
  • Adele Silvagni,
  • Federica Celoro and
  • Roberto Angioli
  • + 5 authors+ 0 author

14 May 2024

The Cancer Genome Atlas (TCGA) has radically changed the history of endometrial cancer by outlining a new classification, based on its molecular characteristics. In the field of oncology, we are approaching the new era of molecular biology, particula...

(This article belongs to the Special Issue Endometrial Cancer: Old Questions and New Perspectives (Volume II))
  • Systematic Review
  • Open Access
2 Citations
2,832 Views
13 Pages

Efficacy of Adding Immune Checkpoint Inhibitors to Chemotherapy Plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials

  • Fumihiko Ando,
  • Akihisa Matsuda,
  • Yuji Miyamoto,
  • Yu Sunakawa and ,
  • Tomoko Asatsuma-Okumura,
  • Yoshiko Iwai and
  • Hiroshi Yoshida
  • + 2 authors+ 0 author

31 July 2025

Background: Immune checkpoint inhibitors (ICIs) have limited efficacy in proficient mismatch repair (pMMR) and microsatellite stability (MSS) metastatic colorectal cancer (mCRC). Inhibition of vascular endothelial growth factor (VEGF) or cytotoxic ch...

(This article belongs to the Section Systematic Review or Meta-Analysis in Cancer Research)
  • Article
  • Open Access
8 Citations
6,043 Views
10 Pages

4 January 2023

Background: Signet ring cell carcinoma (SRCC) is a specific type of gastric cancer. The clinicopathological and molecular characteristics that can be used to predict the response to anti-PD-1 therapy for these patients are still not clear. Methods: P...

(This article belongs to the Section Personalized Therapy in Clinical Medicine)
  • Review
  • Open Access
2 Citations
1,154 Views
20 Pages

Microsatellite Phenotype as a Guide for Immunotherapy in Colorectal Cancer: Current Status and Future Perspectives

  • Evangelos Koustas,
  • Eleni-Myrto Trifylli,
  • Vaios Oraiopoulos,
  • Michalis V. Karamouzis and
  • Panagiotis Sarantis

9 June 2026

The therapeutic armamentarium for colorectal cancer (CRC) has been significantly expanded with the introduction of immunotherapy, particularly immune checkpoint inhibitors (ICIs). However, the response to immunotherapy is strongly dependent on micros...

(This article belongs to the Section Human Genomics and Genetic Diseases)

of 6